Placeholder Image

Subtitles section Play video

  • the US government reached a deal for nearly one million doses of drugmaker Eli Lilly's experimental Koven 19 antibody treatment, which may cost over $1 billion.

  • The pharma giant set on Wednesday once it receives an emergency use authorization from the Food and Drug Administration, it will start delivering 300,000 doses of the treatment within two months.

  • The U.

  • S government will pay $375 million for that first delivery after that, U.

  • S Department of Health and Human Services said the government has an option to buy an additional 650,000 vials for more than $800 million.

  • Three agreement with the US came days after the company said the drug failed to show benefits in hospitalized patients.

  • But Eli Lilly said it remains confident it's treatment can prevent the progression of disease when it has started earlier.

  • There are also questions about the company's facilities.

  • Reuters reported that U.

  • S drug inspectors uncovered serious quality control problems at an Eli Lilly plant that is ramping up to make its anti body therapy.

  • The drugmaker said the issues raised by US regulators after the inspection do not affect the quality or safety of the treatment.

  • Eli Lilly applied for an FDA emergency use authorization of the drug to treat mild to moderate Koven 19 patients earlier this month.

the US government reached a deal for nearly one million doses of drugmaker Eli Lilly's experimental Koven 19 antibody treatment, which may cost over $1 billion.

Subtitles and keywords

B1 INT lilly treatment eli drug authorization government

U.S., Eli Lilly strike deal for potential COVID-19 drug

  • 1 1
    林宜悉   posted on 2020/10/28
Keywords

Go back to previous version